ARTV vs KHC · $37.3M cap vs P/E 12, rev $12.31B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Kraft Heinz Co (KHC) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
ARTV currently screens at market cap $37.3M. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Not investment advice. Open the ARTV and KHC stock pages for the full models.
Not investment advice.